Opioid CME

Click HERE to Access Webinar Link 

Click HERE to Access CME Evaluation 

Learning Objectives:

• Participants will be able to identify the 3 FDA approved medications for Opioid Use Disorder
  (OUD)
• By understanding precipitated withdrawal, participants will be feel confident in starting
  patients on buprenorphine both in the ER/hospital and at home
• Participants will know how to manage common clinical challenges that arise for patients on
  buprenorphine-naloxone (i.e. pregnancy, acute pain and chronic liver disease).

Dr. Krista Brucker is a partner with South Bend Emergency Physicians in the ER at
Memorial Hospital South Bend. She also has an Addiction Medicine practice at Oaklawn
South Bend.

Her interest in Addiction Medicine grew out of her time as a junior faculty member at Indiana
University School of Medicine’s Department of Emergency Medicine. There, she designed and
implemented Project POINT, a collaborative effort aimed at identifying, treating and linking
patients with opioid use disorders to life saving medications and post discharge treatment.
Since moving to South Bend in 2019, Dr Brucker has supported expanded access to medications
for Opioid Use Disorder both within Beacon Health System and through her work in the Addiction
Medicine program at Oaklawn South Bend and with the county’s Opioid Response Team.
Dr. Brucker completed her emergency medicine residency at Northwestern University’s Feinberg
School of Medicine in Chicago, IL. She is board certified in both Emergency and Addiction
Medicine. She is a graduate of Harvard Medical School. and earned her undergraduate degree in
Biochemistry from DePauw University. She was born and raised in Minnesota.
Participants will be able to identify the 3 FDA approved medications for Opioid Use Disorder
(OUD)
By understanding precipitated withdrawal, participants will be feel confident in starting
patients on buprenorphine both in the ER/hospital and at home
Participants will know how to manage common clinical challenges that arise for patients on
buprenorphine-naloxone (i.e. pregnancy, acute pain and chronic liver disease).
This session is intended to support providers who are interested in starting buprenorphinenaloxone
in the ER or hospital/other settings but might feel unsure of how to go about doing it.
We’ll review the common forms of treatment for Opioid Use Disorder and focus on
buprenorphine-naloxone. The session will cover both how to help people move from active drug
use onto buprenorphine as well as how to take care of people who are maintained on
buprenorphine. In addition to discussing routine cases, we’ll also walk through several of the
more common clinical complexities that arise: including patients using fentanyl, pregnancy,
acute pain, liver disease and sedative co-prescribing.